“pfizer” Archives

Entry Author Date Location
Alnylam RNAi Drug Holds Up After Year of Treatment in Small Study 04/21/15 Boston
Blend Therapeutics Taps Former Clinical Data Chief Fromkin As New CEO 04/13/15 Boston
Alzheon Gets $10M to Take Castoff Alzheimer’s Drug Into Pivotal Test 04/08/15 Boston
Gene Therapy’s Rebirth Continues With Bristol, UniQure Cardio Deal 04/06/15 New York
Academia vs. BioPharma: Young Scientists Between A Rock and A Hard Place 04/06/15 Seattle
Mobiquity Acquires European Mobile Consultant Morgan Clark 03/31/15 Boston
Stop the Bleeding: Can Gene Therapy Finally Cure Hemophilia? 03/23/15 National
Biogen Drug Shows Early Promise in Slowing Alzheimer’s Decline 03/20/15 Boston
With $43M, Nimbus Sheds “Discovery” Tag, Heads to First Clinical Test 03/18/15 Boston
23andMe Adds On: More About The Gene-Test Maker’s Drug R&D Ambitions 03/12/15 San Francisco
23andMe Pharma? That’s the Plan, Says the Genetic Test Maker 03/12/15 San Francisco
Bellicum CEO Reflects on Rise From Baylor to Houston Biotech Darling 02/26/15 Texas
Yes to Flexus: The Science And Strategy Behind A Huge Biotech Return 02/26/15 San Francisco
Syndax CEO Says an Immuno-Oncology Thing Happened on the Way to IPO 02/17/15 Boston
Ready, Aim, CRISPR: Will Gene-Editing Tools Hit Their Targets? 02/17/15 National
With FDA Hold Lifted, Esperion Cholesterol Drug Heads to Phase 3 02/09/15 Detroit Ann Arbor
Why Boston Biotech Should Look to London 02/09/15 Boston
East Coast Biotech Roundup: Hamburg, Merck, Annovation, WaVe & More 02/09/15 Boston
FDA’s Hamburg Stepping Down With Biopharma Turnaround as Her Legacy 02/05/15 National
Cancer Drug Developer G1 Therapeutics Closes $33M Series B Round 02/05/15 Raleigh Durham
Biogen Places Gene Therapy Bet in Crowded Hemophilia Space 01/29/15 Boston
From Yeast, Yumanity Looks to Give Rise to Critical Neuro Drugs 01/26/15 Boston
J.P. Morgan 2015: Notes, Thoughts, And Conversations From the Vortex 01/16/15 National
It Had to be You: Why Roche Was The Lone Suitor For Foundation 01/16/15 Boston
One Week Into The New Year, Five Biotechs Reel in $220M Venture Cash 01/08/15 National
CART + CRISPR = 1st-Of-Its-Kind Biotech Deal From Novartis, Intellia 01/07/15 Boston
ASH Roundup: Immunotherapy Stars, Gene Therapy Leaps Ahead 12/11/14 San Francisco
With New Data, Agios Plots Quick Turn into Key Late-Stage Trials 12/07/14 Boston
With Souped-Up Rituxan, Unum Plots First Foray Into T-Cell Therapy 12/01/14 Boston
MassChallenge Winner From MIT Aims to Kill Cancer With a “Squeeze” 11/24/14 Boston
Page 2 of 21 « previous page · next page »